TuHURA Biosciences, Inc. Common Stock

HURA XNAS • PHARMACEUTICAL PREPARATIONS

Historical Short Interest Share

Chase Ink Business Preferred®

Earn Up to 150K Bonus Points

Transfer points to 14+ airline & hotel partners. Up to 40% upgrade value on first class travel. $95/yr.

Apply Now

Market Cap

130M

Short interest (Jul 15)

10.4%

Net Short (Jul 27 ): 0.0%

Borrow Fee

16.50%

↓ 9.2%

Available Shares

↑ 48.8%

Price Chart

Company Overview

TuHURA Biosciences Inc is a phase 3 clinical stage immuno-oncology company with three distinct technologies focused on the development of novel therapeutics designed to overcome primary and acquired resistance to cancer immunotherapies. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. The company operates in one reportable segment, which includes all activities related to advancing therapies for cancer treatment.

Company Info

Exchange: NASDAQ

Industry: PHARMACEUTICAL PREPARATIONS

CIK: 0001498382

Asset Type: CS

Market Data

Market Cap: $134,370,134

Employees: 22

Status: Active

Short Interest

Current Borrow Fee 16.50%

Range: 16.33% - 16.50%

Available Shares 2M

Range: 1.3M - 1.6M

Recent Changes

Fee Change: ↑ 5.3%

Available Change: ↓ 0.0%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime